Skip to main content
IART logo

Integra LifeSciences Holdings Corporation

IARTNASDAQHealthcareMedical Devices

$12.10Today:- (-)1Y −22.39%

As of Oct 26, 2026 close

Market cap
$950.78M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.70$20.49
Volume (live)
-
Avg. volume (3M)
1.17M

Integra LifeSciences Holdings Corporation (IART) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Integra LifeSciences Holdings Corporation stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Hold
Based on 12 unique analysts
(21 total ratings in last 90 days)
High Confidence1.0:1 Buy/Sell

Average Price Target

$14.88
+22.98% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest IART Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ravi Misra
Truist
HoldMaintains
$15.00 → $13.00
Daniel Stauder
Citizens JMP
BuyMaintains
$25.00 → $22.00
Ryan Zimmerman
BTIG
HoldMaintains
-
Travis Steed
BofA Securities
SellReiterates
$14.00
Vik Chopra
BMO Capital
HoldMaintains
$15.00 → $14.00
Robbie Marcus
JP Morgan
SellMaintains
$17.00 → $14.00
Joanne Wuensch
Citi
HoldReiterates
$15.00 → $14.00
Larry Biegelsen
Wells Fargo
HoldReiterates
$15.00 → $13.00
Ryan Zimmerman
BTIG
HoldMaintains
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Richard Newitter
Truist
HoldMaintains
$19.00 → $15.00
Ravi Misra
Truist
HoldMaintains
-
Joanne Wuensch
Citi
HoldMaintains
$19.00 → $15.00
Ryan Zimmerman
BTIG
HoldMaintains
-
Larry Biegelsen
Wells Fargo
HoldMaintains
$18.00 → $15.00
Vik Chopra
BMO Capital
HoldMaintains
$18.00 → $15.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Moumi Mondal
Zacks Equity Research
HoldInitiates Coverage
-
Robbie Marcus
JP Morgan
SellMaintains
$17.00
Robbie Marcus
JP Morgan
SellMaintains
$17.00
Tirthankar Chakraborty
Zacks Equity Research
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IART?

The analyst consensus rating for IART is Hold, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for IART?

The average 12-month price target for IART is $14.88, representing an upside of 23.0% from the Oct 26, 2026 close of $12.10.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.